{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T05:51:18Z","timestamp":1774763478639,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.AJUMS. REC.1397.621"],"award-info":[{"award-number":["IR.AJUMS. REC.1397.621"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Chronic lymphocytic leukemia (CLL) is an adult leukemia presented with clonal accumulation of lymphocytes. Immunophenotypic changes can be effective in predicting clinical course, the survival of patients, and determining first-line treatment. This is a study of the association between immunophenotypic markers with complete blood cell count (CBC) values and clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Peripheral blood samples were collected from 35 newly diagnosed CLL patients. The expression of immunophenotypic markers and CBC were evaluated. Platelet counts and hemoglobin concentration had a significant, inverse association with Rai staging, modified Rai staging, Binet staging systems (all p\u2009&lt;\u20090.001 in both parameters), and splenomegaly (p\u2009=\u20090.001 and 0.007, respectively). The platelet\/lymphocyte ratio (PLR) had a significant, inverse association with Rai staging (p\u2009=\u20090.014), modified Rai staging (p\u2009=\u20090.024), Binet staging systems (p\u2009=\u20090.027), and splenomegaly (p\u2009=\u20090.033). However, CD38, CD25, and double-positive CD56\/CD117 expression, group 3 of innate lymphocyte cells (ILC3s), had no significant association with clinical parameters. In regression analysis, that ILC3s has an inverse correlation with neutrophil\/lymphocyte ratio (r\u2009=\u2009\u22120.340, p\u2009=\u20090.046). Given that there is an inverse association between PLR and advanced clinical stages, it seems that PLR may have prognostic value in CLL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-020-05243-7","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T05:03:57Z","timestamp":1599109437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Marziye","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Vosoughi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehran","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"11","key":"5243_CR1","doi-asserted-by":"publisher","first-page":"19420","DOI":"10.1002\/jcp.28724","volume":"234","author":"T Vosoughi","year":"2019","unstructured":"Vosoughi T, Bagheri M, Hosseinzadeh M, Ehsanpour A, Davari N, Saki N. CD markers variations in chronic lymphocytic leukemia: new insights into prognosis. J Cell Physiol. 2019;234(11):19420\u201339.","journal-title":"J Cell Physiol"},{"key":"5243_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.leukres.2015.10.008","volume":"40","author":"J Kellner","year":"2016","unstructured":"Kellner J, Wierda W, Shpall E, Keating M, McNiece I. Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLL. Leuk Res. 2016;40:54\u20139.","journal-title":"Leuk Res"},{"issue":"1","key":"5243_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2141.2011.09000.x","volume":"157","author":"J Delgado","year":"2012","unstructured":"Delgado J, Espinet B, Oliveira AC, Abrisqueta P, de la Serna J, Collado R, et al. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results. Br J Haematol. 2012;157(1):67\u201374.","journal-title":"Br J Haematol"},{"key":"5243_CR4","first-page":"692","volume":"25","author":"SS Mougalian","year":"2011","unstructured":"Mougalian SS, O\u2019Brien S. Adverse prognostic features in chronic lymphocytic leukemia. Oncology. 2011;25:692\u20139.","journal-title":"Oncology."},{"issue":"1","key":"5243_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","volume":"8","author":"P Cramer","year":"2011","unstructured":"Cramer P, Hallek M. Prognostic factors in chronic lymphocytic leukemia\u2014what do we need to know? Nat Rev Clin Oncol. 2011;8(1):38.","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"5243_CR6","first-page":"279","volume":"2006","author":"E Montserrat","year":"2006","unstructured":"Montserrat E. New prognostic markers in CLL. ASH Education Program Book. 2006;2006(1):279\u201384.","journal-title":"ASH Education Program Book."},{"issue":"10","key":"5243_CR7","first-page":"1621","volume":"63","author":"M Falay","year":"2017","unstructured":"Falay M, \u00d6zet G. Immunophenotyping of chronic lymphocytic leukemia. Clin Lab. 2017;63(10):1621\u20136.","journal-title":"Clin Lab."},{"key":"5243_CR8","doi-asserted-by":"publisher","first-page":"435983","DOI":"10.1155\/2014\/435983","volume":"2014","author":"A Puiggros","year":"2014","unstructured":"Puiggros A, Blanco G, Espinet B. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go. Biomed Res Int. 2014;2014:435983.","journal-title":"Biomed Res Int"},{"issue":"3","key":"5243_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1034\/j.1600-0609.2002.01515.x","volume":"68","author":"V Hjalmar","year":"2002","unstructured":"Hjalmar V, Hast R, Kimby E. Cell surface expression of CD25, CD54, and CD95 on B-and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course. Eur J Haematol. 2002;68(3):127\u201334.","journal-title":"Eur J Haematol"},{"issue":"1","key":"5243_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1182\/blood.V98.1.181","volume":"98","author":"S Ibrahim","year":"2001","unstructured":"Ibrahim S, Keating M, Do K-A, O\u2019Brien S, Huh YO, Jilani I, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98(1):181\u20136.","journal-title":"Blood"},{"issue":"3","key":"5243_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"TJ Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99(3):1023\u20139.","journal-title":"Blood"},{"issue":"5","key":"5243_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","volume":"124","author":"MD Hazenberg","year":"2014","unstructured":"Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5):700\u20139.","journal-title":"Blood"},{"issue":"3","key":"5243_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cyto.b.21614","volume":"94","author":"S Trabanelli","year":"2018","unstructured":"Trabanelli S, Gomez-Cadena A, Salom\u00e9 B, Michaud K, Mavilio D, Landis BN, et al. Human innate lymphoid cells (ILCs): toward a uniform immune-phenotyping. Cytom Part B Clin. 2018;94(3):392\u20139.","journal-title":"Cytom Part B Clin."},{"issue":"2","key":"5243_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.thorsurg.2014.12.003","volume":"25","author":"DE Wood","year":"2015","unstructured":"Wood DE. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening. Thorac Surg Clin. 2015;25(2):185\u201397.","journal-title":"Thorac Surg Clin."},{"issue":"12","key":"5243_CR15","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446\u201356.","journal-title":"Blood"},{"issue":"1","key":"5243_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s13104-018-3926-0","volume":"11","author":"EA Abdelgader","year":"2018","unstructured":"Abdelgader EA, Eltayeb NH, Eltahir TA, Altayeb OA, Fadul EA, Rahman EMA, et al. Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia. BMC Res Notes. 2018;11(1):815.","journal-title":"BMC Res Notes."},{"issue":"1","key":"5243_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jnci.2016.01.003","volume":"28","author":"AM Kamel","year":"2016","unstructured":"Kamel AM, El-Sharkawy NM, Osman RA, El-Fattah EKA, El-Noshokaty E, El-Hamid TA, et al. Adhesion molecules expression in CLL: potential impact on clinical and hematological parameters. J Egypt Natl Canc Inst. 2016;28(1):31\u20137.","journal-title":"J Egypt Natl Canc Inst."},{"issue":"4","key":"5243_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2141.2005.05659.x","volume":"130","author":"M Gentile","year":"2005","unstructured":"Gentile M, Mauro FR, Calabrese E, Propris MSD, Giammartini E, Mancini F, et al. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol. 2005;130(4):549\u201357.","journal-title":"Br J Haematol"},{"issue":"2","key":"5243_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/ejh.ejh_51_17","volume":"43","author":"AH Abdelrahman","year":"2018","unstructured":"Abdelrahman AH, Ibrahim MH, Hamza MT, Eid OM, Hassan EM, Kamel SA, et al. Relevance of CD49d and CD38 expressions as predictors of disease progression in chronic lymphocytic leukemia. Egypt J Haematol. 2018;43(2):88.","journal-title":"Egypt J Haematol."},{"issue":"2","key":"5243_CR20","first-page":"564","volume":"31","author":"IA Ahmedy","year":"2018","unstructured":"Ahmedy IA, Alhassanin SA, Moussa NS. Role of CD305 and CD38 in chronic lymphocytic leukemia clinical relevance. Menoufia Med J. 2018;31(2):564.","journal-title":"Menoufia Med J."},{"issue":"10","key":"5243_CR21","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00277-012-1492-4","volume":"91","author":"L Shvidel","year":"2012","unstructured":"Shvidel L, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y, Tadmor T, et al. Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients. Ann Hematol. 2012;91(10):1597\u2013602.","journal-title":"Ann Hematol"},{"key":"5243_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.17219\/acem\/74437","volume":"27","author":"E Grywalska","year":"2018","unstructured":"Grywalska E, Bartkowiak-Emeryk M, Pasiarski M, Olszewska-Bozek K, Mielnik M, Podgajna M, et al. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease. Adv Clin Exp Med. 2018;27:987\u201399.","journal-title":"Adv Clin Exp Med."},{"issue":"11","key":"5243_CR23","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.3324\/haematol.2016.144725","volume":"101","author":"I de Weerdt","year":"2016","unstructured":"de Weerdt I, Vera van Hoeven J, Endstra S, Hofland T, Hazenberg MD, Kater AP. Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia. Haematologica. 2016;101(11):e461.","journal-title":"Haematologica"},{"issue":"1","key":"5243_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13104-019-4239-7","volume":"12","author":"AA Basabaeen","year":"2019","unstructured":"Basabaeen AA, Abdelgader EA, Babekir EA, Eltayeb NH, Altayeb OA, Fadul EA, et al. Clinical presentation and hematological profile among young and old chronic lymphocytic leukemia patients in Sudan. BMC Res Notes. 2019;12(1):202.","journal-title":"BMC Res Notes."},{"issue":"1","key":"5243_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12878-016-0051-y","volume":"16","author":"A Sall","year":"2016","unstructured":"Sall A, Tour\u00e9 AO, Sall FB, Ndour M, Fall S, S\u00e8ne A, et al. Characteristics of chronic lymphocytic leukemia in Senegal. BMC Hematol. 2016;16(1):10.","journal-title":"BMC Hematol."},{"issue":"1","key":"5243_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/IBRR\/2017\/31359","volume":"7","author":"RAEM Ahmed","year":"2017","unstructured":"Ahmed RAEM, Osman IM. Clinical and haematological pattern of chronic lymphocytic leukaemia in sudanese patients. Int Blood Res Rev. 2017;7(1):1\u201310.","journal-title":"Int Blood Res Rev."},{"issue":"10","key":"5243_CR27","doi-asserted-by":"publisher","first-page":"FSO344","DOI":"10.4155\/fsoa-2018-0061","volume":"4","author":"Z Bakouny","year":"2018","unstructured":"Bakouny Z, Rassy EE, Yared F, Lutfallah AA, Ghosn M, Farhat F, et al. Is there a role for the platelet-to-lymphocyte ratio in chronic lymphocytic leukemia? Future Sci OA. 2018;4(10):FSO344.","journal-title":"Future Sci OA."}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05243-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T09:20:38Z","timestamp":1630660838000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05243-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05243-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-42629\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-42629\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the procedures performed in the studies involving human participants were in accordance with the ethical standards of the local ethics committee of Ahvaz Jundishapur University of Medical Sciences (IR. AJUMS. REC.1397.621). Written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}